Internal Medicine, Endocrinology, Diabetes, & Metabolism · San Antonio, TX
NPI
1861656548
Since 2008
Specialty
Internal Medicine, Endocrinology, Diabetes, & Metabolism
Code 207RE0101X
Group practices
1
Medicare group memberships
Hospitals
0
Hospital affiliations
5107 Medical Dr
San Antonio, TX, 78229
Phone (210) 614-8612
Groups this clinician bills Medicare through
Medicare paid, 2024
$321K
19,041 services
Medicare patients, 2024
719
Average age 73
Drug cost, 2024
$3.5M
7,144 prescriptions
Company payments, 2025
$4,215
From 29 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Mahendra Ghanta was code 36415 (venipuncture blood collection), 1,629 times for 667 patients. In total Mahendra Ghanta billed 19,041 services in 91 codes, and Medicare paid $321K.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-02-26.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| 36415 Venipuncture Blood Collection | Office | 1,629 | 667 | $5.84 | $9,514 |
| 99214 Office E&M - Established | Office | 1,535 | 624 | $87.79 | $135K |
| 80053 Clinical Chemistry | Office | 1,351 | 627 | $10.24 | $14K |
| 83036 Blood Count | Office | 1,181 | 522 | $9.39 | $11K |
| 84443 Clinical Chemistry | Office | 1,019 | 505 | $16.34 | $17K |
| 80061 Clinical Chemistry | Office | 980 | 489 | $12.94 | $13K |
| 84439 Clinical Chemistry | Office | 882 | 424 | $8.78 | $7,740 |
| 85025 Blood Count | Office | 648 | 395 | $7.56 | $4,897 |
| G2211 Visit complexity inherent to evaluation and management associated with medical care services that serve as the continuing focal point for all needed health care services and/or with medical care services that are part of ongoing care related to a patient's | Office | 581 | 429 | $12.99 | $7,548 |
| 82306 Clinical Chemistry | Office | 444 | 345 | $28.59 | $13K |
| 95251 Test - Miscellaneous | Office | 431 | 185 | $25.65 | $11K |
| 84100 Clinical Chemistry | Office | 427 | 270 | $4.59 | $1,960 |
| 83970 Clinical Chemistry | Office | 268 | 176 | $40.08 | $11K |
| 82728 Clinical Chemistry | Office | 183 | 126 | $13.22 | $2,420 |
| 82985 Clinical Chemistry | Office | 172 | 138 | $16.16 | $2,780 |
By year: 2022 $111K for 4,704 services; 2023 $197K for 10,661 services; 2024 $321K for 19,041 services.
Lab tests billed to Medicare, 2024
| Test code | Tests | Patients | Paid per test | Medicare paid |
|---|---|---|---|---|
| 36415 Venipuncture Blood Collection | 1,629 | 667 | $5.84 | $9,514 |
| 80053 Clinical Chemistry | 1,351 | 627 | $10.24 | $14K |
| 83036 Blood Count | 1,181 | 522 | $9.39 | $11K |
| 84443 Clinical Chemistry | 1,019 | 505 | $16.34 | $17K |
| 80061 Clinical Chemistry | 980 | 489 | $12.94 | $13K |
| 84439 Clinical Chemistry | 882 | 424 | $8.78 | $7,740 |
| 85025 Blood Count | 648 | 395 | $7.56 | $4,897 |
| 82306 Clinical Chemistry | 444 | 345 | $28.59 | $13K |
| 84100 Clinical Chemistry | 427 | 270 | $4.59 | $1,960 |
| 83970 Clinical Chemistry | 268 | 176 | $40.08 | $11K |
Medicare prescription drug claims, 2024
In 2024, the drug Mahendra Ghanta prescribed most often to Medicare patients was Levothyroxine Sodium, with 546 prescriptions and refills. In total Mahendra Ghanta wrote 7,144 Medicare prescriptions that cost $3.5M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Levothyroxine Sodium Generic | 546 | 1,556 | 218 | $6,324 |
| Ozempic Semaglutide | 508 | 743 | 148 | $679K |
| Atorvastatin Calcium Generic | 468 | 1,353 | 201 | $4,904 |
| Mounjaro Tirzepatide | 330 | 419 | 108 | $441K |
| Rosuvastatin Calcium Generic | 325 | 919 | 131 | $4,189 |
| Metformin Hcl Er Metformin Hcl | 278 | 806 | 121 | $2,927 |
| Synthroid Levothyroxine Sodium | 228 | 580 | 83 | $23K |
| Losartan Potassium Generic | 210 | 589 | 91 | $2,185 |
| Ezetimibe Generic | 188 | 556 | 82 | $4,087 |
| Jardiance Empagliflozin | 171 | 475 | 74 | $265K |
| Nano 2nd Gen Pen Needle Pen Needle, Diabetic | 171 | 476 | 94 | $18K |
| Metformin Hcl Generic | 158 | 462 | 65 | $1,209 |
| Lantus Solostar Insulin Glargine,hum.Rec.Anlog | 120 | 369 | 70 | $20K |
| Farxiga Dapagliflozin Propanediol | 110 | 275 | 43 | $148K |
| Amlodipine Besylate Generic | 98 | 286 | 39 | $739 |
Brand drugs: 3,030 claims; generic drugs: 3,660 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Mahendra Ghanta $4,215 ($4,215 in general payments such as food, travel and fees) from 29 companies. The largest payer was Lilly USA, LLC with $414.
| Company | Payments | Amount |
|---|---|---|
| Lilly USA, LLC LLY | 21 | $414 |
| Novo Nordisk Inc NVO | 18 | $354 |
| Corcept Therapeutics CORT | 11 | $350 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | 18 | $298 |
| Medtronic, Inc. MDT | 12 | $286 |
| Sanofi-Aventis U.S. LLC SNY | 14 | $279 |
| Amgen Inc. AMGN | 18 | $263 |
| Mannkind Corporation MNKD | 17 | $245 |
| Abbott Laboratories ABT | 8 | $215 |
| Ascensia Diabetes Care Us Inc. | 10 | $212 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.